BJDX
Bluejay Diagnostics Inc
NASDAQ: BJDX · HEALTHCARE · MEDICAL DEVICES
$1.88
+4.44% today
Updated 2026-04-30
Market cap
$1.96M
P/E ratio
—
P/S ratio
54.99x
EPS (TTM)
$-15.25
Dividend yield
—
52W range
$2 – $17
Volume
0.2M
Bluejay Diagnostics Inc (BJDX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.69M | $-508710.00 | $-4.37M | $-7.74M | $-8.31M | $-7.82M | $-6.05M |
| Capital expenditures | $6021.00 | $23947.00 | $23947.00 | $1.20M | $704166.00 | $306783.00 | $173735.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $14815.00 | $7370.00 | $68458.00 | $433004.00 | $189245.00 | $20094.00 | $6.00 |
| Free cash flow | $-1.70M | $-532657.00 | $-4.39M | $-8.94M | $-9.02M | $-8.13M | $-6.23M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | $17667.00 | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |